Zoetis, Inc. (New York Stock Exchange:ZTS)
About the company
Zoetis, Inc. discovers, develops and manufactures a portfolio of animal health medicines and vaccines. The company operates through the following segments: United States &International. Its products are complemented by diagnostic products, genetic tests, bio devices and services. These are designed to meet the needs of veterinarians and the livestock farmers and companion animal. The company provides its services though five categories namely, anti-invectives, vaccines, parasitic ides, medicated feed additives, and other pharmaceuticals. Zoetis was founded in 1952 and is headquartered in Parsippany, NJ.
Gross Margin (in %)
Operating Margin (in %)
Net Margin (in %)
Dividend Yield (in %)
|Name||Ticker||Market capitalization (in USD Million)||Revenues (in USD Million)||Price/Book||Price/Earning||Net margin (in %)|
|BridgeBio Pharma, Inc.||BBIO||3680.82||41.00||9.69||-12.68||-718.08|
|Taro Pharmaceutical Industries Ltd.||TARO||2544.10||645.00||1.22||10.54||37.88|
|Abeona Therapeutics, Inc.||ABEO||210.80||3.00||2.15||-2.07||75.95|
|Kindred Biosciences, Inc.||KIN||150.93||4.00||2.51||-2.21||None|
|Cocrystal Pharma, Inc.||COCP||53.55||2.00||1.96||-0.92||-733.84|
|China Pharma Holdings, Inc.||CPHI||25.04||10.00||2.99||-1.16||-214.63|
|Jaguar Health, Inc.||JAGX||4.86||5.00||3.60||0.07||-887.14|
Latest insider transactions
|Date||Role||Name||Transaction||Quantity||Quantity Owned After|
How do you pick the next stock to invest in? One way would be to spend days of research browsing through thousands of ...
Trianni and Zoetis Announce Agreement to Develop a Transgenic Antibody Discovery Platform for Use in Animal Health
Trianni, Inc. (TRIANNI) and Zoetis (NYSE: ZTS) today announced a collaboration for the development of transgenic monoclonal antibody platforms for the discovery of new veterinary treatments.
(NYSE:ZTS) will host a webcast and conference call at 8:30 a.m. (ET) on Thursday, Aug. 6, 2020. Chief Executive Officer ...
Collaboration will enhance Zoetis's pipeline of novel monoclonal antibodies and hasten development of therapeutics for a range of animal diseases.
Fulton Bank N. A. raised its position in shares of Zoetis Inc (NYSE:ZTS) by 148.3% in the 2nd quarter, according to its most ...
Engineers Gate Manager LP boosted its stake in shares of Zoetis Inc (NYSE:ZTS) by 27.8% in the 1st quarter, according to the ...
The Canadian Animal Health Institute (CAHI) is pleased to announce that Toni Bothwell, Director, Regulatory Affairs & Pharmacovigilance at Zoetis Canada is the 2020 recipient of its internal ...